Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-19
DOI
10.1038/s41467-020-20723-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer
- (2019) Chao Lin et al. GUT
- Blocking TREM-1+ Tumor-associated macrophages induced by hypoxia reverses immunosuppression and anti-PD-L1 resistance in liver cancer
- (2019) Qinchuan Wu et al. HEPATOLOGY
- The softness of tumour-cell-derived microparticles regulates their drug-delivery efficiency
- (2019) Qingle Liang et al. Nature Biomedical Engineering
- Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation
- (2019) Ji-Chang Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy
- (2019) Mónica Pascual-García et al. Nature Communications
- CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer
- (2019) Luigi Racioppi et al. Nature Communications
- Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators
- (2019) João Conniot et al. Nature Nanotechnology
- Preclinical evaluation of mRNA trimannosylated lipopolyplexes as therapeutic cancer vaccines targeting dendritic cells
- (2018) A. Le Moignic et al. JOURNAL OF CONTROLLED RELEASE
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment
- (2018) Elisa Peranzoni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The tumour microenvironment creates a niche for the self-renewal of tumour-promoting macrophages in colon adenoma
- (2018) Irene Soncin et al. Nature Communications
- Therapeutic Prospects of Extracellular Vesicles in Cancer Treatment
- (2018) Daria S. Chulpanova et al. Frontiers in Immunology
- Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
- (2018) Jun Gong et al. Journal for ImmunoTherapy of Cancer
- M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors
- (2018) Yeon Woong Choo et al. ACS Nano
- Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer
- (2018) Simon R. Lord et al. Cell Metabolism
- Immunomodulators targeting the PD-1/PD-L1 protein-protein interaction: From antibodies to small molecules
- (2018) Jeffrey Yang et al. MEDICINAL RESEARCH REVIEWS
- Radiation combined with macrophage depletion promotes adaptive immunity and potentiates checkpoint blockade
- (2018) Keaton I Jones et al. EMBO Molecular Medicine
- Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy
- (2018) Jinfang Zhang et al. TRENDS IN BIOCHEMICAL SCIENCES
- Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial
- (2017) Amir Sonnenblick et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Exosomes from M1-Polarized Macrophages Potentiate the Cancer Vaccine by Creating a Pro-inflammatory Microenvironment in the Lymph Node
- (2017) Lifang Cheng et al. MOLECULAR THERAPY
- Reprogramming Tumor-Associated Macrophages To Reverse EGFRT790M Resistance by Dual-Targeting Codelivery of Gefitinib/Vorinostat
- (2017) Huige Peng et al. NANO LETTERS
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Metformin-treated cancer cells modulate macrophage polarization through AMPK-NF-κB signaling
- (2017) Chi-Fu Chiang et al. Oncotarget
- Extracellular vesicles for drug delivery
- (2016) Pieter Vader et al. ADVANCED DRUG DELIVERY REVIEWS
- Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy
- (2016) Yoshihiro Komohara et al. ADVANCED DRUG DELIVERY REVIEWS
- A Breakthrough: Macrophage-Directed Cancer Immunotherapy
- (2016) C. D. Mills et al. CANCER RESEARCH
- Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
- (2016) Mercedes Tkach et al. CELL
- Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles
- (2016) Jingwei Ma et al. CELL RESEARCH
- Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
- (2016) Jonathan M. Pitt et al. IMMUNITY
- Drug delivery to macrophages: Challenges and opportunities
- (2016) Yihua Pei et al. JOURNAL OF CONTROLLED RELEASE
- Metformin: An anti-diabetic drug to fight cancer
- (2016) Marie Daugan et al. PHARMACOLOGICAL RESEARCH
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Learning from PD-1 Resistance: New Combination Strategies
- (2016) Xia Bu et al. TRENDS IN MOLECULAR MEDICINE
- A novel platform for cancer therapy using extracellular vesicles
- (2015) Naoomi Tominaga et al. ADVANCED DRUG DELIVERY REVIEWS
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging
- (2015) Roy L. Maute et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metformin prevents cancer metastasis by inhibiting M2-like polarization of tumor associated macrophages
- (2015) Ling Ding et al. Oncotarget
- Transformation of Cell-Derived Microparticles into Quantum-Dot-Labeled Nanovectors for Antitumor siRNA Delivery
- (2014) Gang Chen et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
- (2014) Marina Colombo et al. Annual Review of Cell and Developmental Biology
- Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
- (2014) Carola H. Ries et al. CANCER CELL
- Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors
- (2012) Hélène Salmon et al. JOURNAL OF CLINICAL INVESTIGATION
- Delivery of chemotherapeutic drugs in tumour cell-derived microparticles
- (2012) Ke Tang et al. Nature Communications
- Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
- (2011) I. Ben Sahra et al. CANCER RESEARCH
- In vivo optical molecular imaging and analysis in mice using dorsal window chamber models applied to hypoxia, vasculature and fluorescent reporters
- (2011) Gregory M Palmer et al. Nature Protocols
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
- (2010) Kai Kessenbrock et al. CELL
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
- (2009) G. Solinas et al. JOURNAL OF LEUKOCYTE BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More